京新药业：累计回购约4727.13万股

Group 1 - The company, Jingxin Pharmaceutical, announced a share buyback of approximately 47.27 million shares, representing 5.49% of its total share capital, with a total expenditure of about 609 million yuan [1] - The highest and lowest purchase prices during the buyback were 14.41 yuan and 11.86 yuan per share, respectively [1] - As of the report, Jingxin Pharmaceutical's market capitalization stands at 17.5 billion yuan [1] Group 2 - For the first half of 2025, the revenue composition of Jingxin Pharmaceutical is as follows: finished drugs account for 58.28%, raw materials account for 22.44%, medical devices account for 17.32%, and other businesses account for 1.95% [1]